Collaborators

ViGene Biosciences, Inc. 

ViGene Biosciences will manufacture PrimeVax’s dengue-2 #1710 virus to GMP specifications for PrimeVax’s human clinical trial needs. ViGene has a track record of producing genetically-modified and unmodified therapeutic virus strains for human clinical trials.